Fortis Healthcare Q1 FY27 Results: Revenue Rs 2,545 Cr, PAT Rs 268 Cr and Key Highlights
- August 7, 2026
- Posted by: Kunal Singla
- Category: News
Fortis Healthcare Q1 FY27 results declared Aug 6, 2026. Revenue Rs 2,545 Cr (+17.46% YoY). PAT Rs 268 Cr (+1.73% YoY). CMP Rs 920.0 (-0.54%).
Fortis Healthcare Q1 FY27 results were announced on August 6, 2026, on a Consolidated basis. Fortis Healthcare Q1 FY27 results show revenue grew +17.46% year-on-year to Rs 2,545 Cr from Rs 2,166 Cr in Q1 FY26, reflecting sustained demand in the Healthcare segment. The broader BSE Healthcare index also reflected mixed sentiment during the quarter.
Operating profit improved +6.69% YoY to Rs 415 Cr from Rs 389 Cr, indicating stronger operational efficiency. PAT rose +1.73% YoY to Rs 268.00 Cr from Rs 263.00 Cr in Q1 FY26. The quarterly numbers offer a detailed picture of how the company is navigating the current healthcare environment.
Click Here – Get Free Investment Predictions
Fortis Healthcare Q1 FY27 Financial Highlights
| Metric | Q1 FY27 (Rs Cr) | Q1 FY26 (Rs Cr) | YoY Change |
|---|---|---|---|
| Fortis Healthcare Revenue | 2,545 | 2,166 | +17.46% |
| Operating Profit | 415 | 389 | +6.69% |
| Net Profit (PAT) | 268 | 263 | +1.73% |
| Reporting Basis | Consolidated | ||
Fortis Healthcare Q1 FY27 Performance Analysis
Check the Univest Screener for Live Data on This Stock
Fortis Healthcare Q1 FY27 results reflect marginal fundamentals across key financial parameters. Revenue momentum continued on a strong footing with the top line reaching Rs 2,545 Cr for the April to June 2026 quarter.
Operating profit stood at Rs 415 Cr, expanding +6.69% YoY. Margin improvement signals better cost absorption and product mix optimisation.
PAT of Rs 268 Cr marks a +1.73% year-on-year improvement. Investors monitoring Fortis Healthcare Q1 FY27 results will note this as a key milestone for FY27 tracking.
Key Business Factors in Fortis Healthcare Q1 FY27 Results
Revenue Growth Momentum in the Healthcare Segment
Fortis Healthcare Q1 FY27 results demonstrate consistent top-line expansion, with revenue rising +17.46% YoY to Rs 2,545 Cr. Volume-led growth and pricing discipline in key markets drove the uptick.
Operating Margin Expansion Signals Efficiency Gains
Operating profit in Fortis Healthcare Q1 FY27 results rose +6.69% YoY to Rs 415 Cr. This reflects tighter cost control, better product mix, and operating leverage as the company scales volumes in core business lines.
PAT Performance and Profitability Trend
Net profit in Fortis Healthcare Q1 FY27 results stood at Rs 268 Cr (+1.73% YoY). The sustained PAT growth reflects the company’s improving financial profile.
Dividend Details
No dividend was announced along with Fortis Healthcare Q1 FY27 results. The company is likely retaining earnings for reinvestment into growth capex and working capital requirements.
FY27 Outlook for Fortis Healthcare
Fortis Healthcare is positioned to maintain growth momentum into Q2 FY27 and beyond, supported by order visibility, operational improvements, and sector tailwinds. Management guidance points toward continued expansion in the Healthcare business with a focus on margin improvement and market share consolidation. Investors tracking Fortis Healthcare Q1 FY27 results are advised to consult a SEBI-registered financial advisor before making decisions.
Fortis Healthcare Stock Performance After Q1 FY27 Results
Download the Univest iOS App or Univest Android App to track Fortis Healthcare live price and get daily stock recommendations.
Fortis Healthcare shares were trading lower at Rs 920.0 (-0.54%) on August 6, 2026, following the declaration of Fortis Healthcare Q1 FY27 results. The stock reaction reflects investor sentiment on near-term earnings trajectory and sector outlook. CMP stood at Rs 920.0 on the results date, with a 52-week range reflecting the broader market sentiment toward the healthcare sector.
Key Risks for Fortis Healthcare
Sector-Specific Headwinds
Rising operational costs, competition from hospital chains, and insurance penetration risks could limit upside.
Valuation and Earnings Risk
Valuation risk remains if earnings growth fails to sustain at current levels over the next two to three quarters.
Operational and Financial Risk
Subsidiary-level losses or underperformance in overseas operations could drag consolidated PAT lower.
Conclusion
Fortis Healthcare Q1 FY27 results demonstrate marginal financial performance with revenue at Rs 2,545 Cr and PAT at Rs 268 Cr on a Consolidated basis. Operating leverage and disciplined cost management will be key drivers for the rest of FY27. Investors should track upcoming management commentary on growth drivers and sector developments before taking positions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Fortis Healthcare Q1 FY27 Results
When were Fortis Healthcare Q1 FY27 results declared?
Ans. Fortis Healthcare Q1 FY27 results were declared on August 6, 2026. The results cover the April to June 2026 quarter on a Consolidated basis.
What was Fortis Healthcare revenue in Q1 FY27?
Ans. Fortis Healthcare Q1 FY27 results show revenue of Rs 2,545 Cr, +17.46% compared to Rs 2,166 Cr in Q1 FY26.
What was Fortis Healthcare PAT in Q1 FY27?
Ans. Net profit (PAT) in Fortis Healthcare Q1 FY27 results was Rs 268 Cr, +1.73% year-on-year.
Did Fortis Healthcare declare a dividend in Q1 FY27?
Ans. No dividend was declared alongside Fortis Healthcare Q1 FY27 results. Investors should check the official company announcements on BSE and NSE for any future dividend declarations.
What is the FY27 outlook for Fortis Healthcare?
Ans. Fortis Healthcare management has outlined a focus on revenue scaling and margin improvement for the remainder of FY27. Sector tailwinds and order book visibility will be key monitorables.
How did the Fortis Healthcare stock react to Q1 FY27 results?
Ans. Fortis Healthcare shares were trading lower at Rs 920.0 (-0.54%) on August 6, 2026, following the Fortis Healthcare Q1 FY27 results announcement. Investors should consult a SEBI-registered financial advisor before acting on price movements.
